Delving into the Latest Updates on Jinrui Foundation with Synapse

Overview

Tags

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

EGFR x EGFR L858R x EGFR T790M x HER2 x HER4	1

The main purpose of the trial is to evaluate the safety and tolerability of JRF103 tablets in patients with advanced solid tumors, as well as to evaluate the pharmacokinetic characteristics of JRF103 tablets in patients with advanced solid tumors and the preliminary anti-tumor efficacy of JRF103 tablets, and to provide recommended doses for subsequent studies.

Start Date16 Apr 2021

Sponsor / Collaborator

Jinrui FoundationStartup

100 Clinical Results associated with Jinrui Foundation

Login to view more data

0 Patents (Medical) associated with Jinrui Foundation

Login to view more data

100 Deals associated with Jinrui Foundation

Login to view more data

100 Translational Medicine associated with Jinrui Foundation

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data